NASDAQ
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a current ratio of 7.69x as of Monday, May 25, 2026. This represents a 59.01% decrease compared to its 12-month average of 18.76x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.